Recent Recall of Iron Reagent-Investigation of Potential Reagent Contamination and Assay Improvement Strategy.

IF 1.8 Q3 MEDICAL LABORATORY TECHNOLOGY Journal of Applied Laboratory Medicine Pub Date : 2024-11-04 DOI:10.1093/jalm/jfae071
Madhusudhanan Narasimhan, Kefyalew Jaleta, Shishir Adhikari, Mizanu Berihun, Kavithalakshmi SataraNatarajan, Lenin Mahimainathan, Jing Cao, Patricia Mary Jones, Ibrahim Hashim, Alagar R Muthukumar
{"title":"Recent Recall of Iron Reagent-Investigation of Potential Reagent Contamination and Assay Improvement Strategy.","authors":"Madhusudhanan Narasimhan, Kefyalew Jaleta, Shishir Adhikari, Mizanu Berihun, Kavithalakshmi SataraNatarajan, Lenin Mahimainathan, Jing Cao, Patricia Mary Jones, Ibrahim Hashim, Alagar R Muthukumar","doi":"10.1093/jalm/jfae071","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recently, a major manufacturer recalled several lots of iron assay reagent due to positive bias of roughly 15%-30% and the cause remains unknown. This study investigated the root cause of this positive bias and evaluated a simple practical approach to improve the assay.</p><p><strong>Methods: </strong>Performance comparison of recalled and unimpacted iron assay kits was done utilizing calibrators, quality control (QC) materials, and 42 remnant patient samples. Spectral scan and trace elements analysis of R1 and R2 reagents was performed. Copper (Cu) and thiourea (TU) spiking experiments were utilized to elucidate the cause and prevention of positive bias seen with recalled lots.</p><p><strong>Results: </strong>Iron measurements in QC materials and patient samples using recalled reagents generated a positive bias of 17.5% and 21%, respectively. Correspondingly, the recalled R2 reagents, but not R1, showed a rise in basal absorbance along with an unanticipated presence of Cu (22.7 µg/dL) and lead (7.5 µg/L). Cu spiking to recalled and unimpacted R2 reagent intensified the reagent color besides falsely increasing its absorbance, calibration factor, and patient iron measurements. Interestingly, addition of TU (65 mmol/L) to R2 reagent from unimpacted lot prevented the short-term and prolonged Cu-induced spurious rise in calibration factor and patient iron estimations.</p><p><strong>Conclusions: </strong>We conclude that accidental copper contamination of R2 reagent during manufacturing could be a reason underlying the positive bias in the recalled iron reagent lots. Addition of TU in ferene-containing R2 reagent is a simple and effective means to prevent Cu-induced false elevation in iron values.</p>","PeriodicalId":46361,"journal":{"name":"Journal of Applied Laboratory Medicine","volume":" ","pages":"1040-1052"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jalm/jfae071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recently, a major manufacturer recalled several lots of iron assay reagent due to positive bias of roughly 15%-30% and the cause remains unknown. This study investigated the root cause of this positive bias and evaluated a simple practical approach to improve the assay.

Methods: Performance comparison of recalled and unimpacted iron assay kits was done utilizing calibrators, quality control (QC) materials, and 42 remnant patient samples. Spectral scan and trace elements analysis of R1 and R2 reagents was performed. Copper (Cu) and thiourea (TU) spiking experiments were utilized to elucidate the cause and prevention of positive bias seen with recalled lots.

Results: Iron measurements in QC materials and patient samples using recalled reagents generated a positive bias of 17.5% and 21%, respectively. Correspondingly, the recalled R2 reagents, but not R1, showed a rise in basal absorbance along with an unanticipated presence of Cu (22.7 µg/dL) and lead (7.5 µg/L). Cu spiking to recalled and unimpacted R2 reagent intensified the reagent color besides falsely increasing its absorbance, calibration factor, and patient iron measurements. Interestingly, addition of TU (65 mmol/L) to R2 reagent from unimpacted lot prevented the short-term and prolonged Cu-induced spurious rise in calibration factor and patient iron estimations.

Conclusions: We conclude that accidental copper contamination of R2 reagent during manufacturing could be a reason underlying the positive bias in the recalled iron reagent lots. Addition of TU in ferene-containing R2 reagent is a simple and effective means to prevent Cu-induced false elevation in iron values.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
最近召回的铁试剂--潜在试剂污染调查和化验改进策略。
背景:最近,一家大型制造商召回了几个批次的铁测定试剂,原因是出现了大约 15%-30%的阳性偏差,且原因不明。本研究调查了造成这种正偏差的根本原因,并评估了一种简单实用的方法来改进化验结果:方法:利用校准物、质控(QC)材料和 42 份残留患者样本,对召回和未受影响的铁测定试剂盒进行了性能比较。对 R1 和 R2 试剂进行了光谱扫描和微量元素分析。利用铜(Cu)和硫脲(TU)加标实验来阐明回收批次出现正偏差的原因和预防措施:结果:使用回收试剂测量质控材料和患者样本中的铁分别产生了 17.5% 和 21% 的正偏差。相应地,召回的 R2 试剂(而非 R1 试剂)显示出基底吸光度的上升,以及未预期的铜(22.7 µg/dL)和铅(7.5 µg/L)的存在。在回收的和未受影响的 R2 试剂中添加铜,除了错误地增加吸光度、校准因子和患者铁测量值外,还加剧了试剂的颜色。有趣的是,在未受影响批次的 R2 试剂中添加 TU(65 毫摩尔/升)可防止由铜引起的校准因子和患者铁估算值的短期和长期假性上升:我们得出结论,R2 试剂在生产过程中意外受到铜污染可能是导致召回的铁试剂批次出现正偏差的原因。在含阿魏的 R2 试剂中添加 TU 是防止铜导致铁值错误升高的一种简单而有效的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Applied Laboratory Medicine
Journal of Applied Laboratory Medicine MEDICAL LABORATORY TECHNOLOGY-
CiteScore
3.70
自引率
5.00%
发文量
137
期刊最新文献
Performance Characteristics of a Calculated Index Control Method for the phi Multianalyte Assay with Algorithmic Analysis. Unraveling Uncertainty: The Impact of Biological and Analytical Variation on the Prediction Uncertainty of Categorical Prediction Models. Fundamental Uncertainty: Interplatform Inconsistency of FDA-Cleared Serological Tests. Commentary on Myocarditis or Myositis? Rising, Declining, and Rising of Critical Cardiac Troponin T Levels in a Patient Post Immune Checkpoint Inhibitor Therapy. Myocarditis or Myositis? Rising, Declining, and Rising of Critical Cardiac Troponin T Levels in a Patient Post Immune Checkpoint Inhibitor Therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1